Biocardia Inc. buy me8
Start price
15.11.23
/
0%
€0.81
Target price
15.11.24
-
Performance (%)
-56.52%
Price
07.05.24
€0.39
Summary
This prediction is currently active. Massive losses of -56.52% have been the result for the BUY prediction by me8. This prediction currently runs until 15.11.24. The prediction end date can be changed by me8 at any time. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocardia Inc. | - | - |
| iShares Core DAX® | 3.178% | 0.980% |
| iShares Nasdaq 100 | 2.972% | 0.925% |
| iShares Nikkei 225® | 0.545% | -4.556% |
| iShares S&P 500 | 2.367% | 0.833% |
According to me8 what are the pros and cons of Biocardia Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
Cons
high free float
Comments by me8 for this prediction
In the thread Biocardia Inc. diskutieren
Buy Biocardia Inc.
Stopped prediction by me8 for Biocardia Inc.
Biocardia Inc.
Start price
Target price
Perf. (%)
€4.53
14.12.20
14.12.20
€5.00
14.12.21
14.12.21
-24.50%
29.01.21
29.01.21
Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
high free float
